⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4546283 | 0.78 | LGALS9 (0.37) | — | |
| SCHEMBL17590144 | 0.78 | LGALS8 (0.31) | — | |
| SCHEMBL4546311 | 0.78 | LGALS8 (0.31) | — | |
| SCHEMBL9029257 | 0.77 | SLC5A2 (0.43) | — | |
| SCHEMBL9029247 | 0.77 | SLC5A2 (0.43) | — | |
| SCHEMBL10436007 | 0.77 | SLC5A2 (0.43) | — | |
| SCHEMBL6384991 | 0.76 | OGA (0.31) | — | |
| SCHEMBL27777436 | 0.76 | SLC5A2 (0.45) | — | |
| SCHEMBL27933773 | 0.76 | SLC5A2 (0.45) | — | |
| SCHEMBL10767838 | 0.76 | SLC5A2 (0.45) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8987430-B2 | Efficient and scalable process for the manufacture of fondaparinux sodium | RELIABLE BIOPHARMACEUTICAL CORPORATION (US) | 2015-03-24 | — | — | US | disclosed |
| US-20130261291-A1 | EFFICIENT AND SCALABLE PROCESS FOR THE MANUFACTURE OF FONDAPARINUX SODIUM | RELIABLE BIOPHARMACEUTICAL CORPORATION (US) | 2013-10-03 | — | — | US | disclosed |
| US-8420790-B2 | Efficient and scalable process for the manufacture of Fondaparinux sodium | RELIABLE BIOPHARMACEUTICAL CORPORATION (US) | 2013-04-16 | — | — | US | disclosed |
| US-20120116066-A1 | EFFICIENT AND SCALABLE PROCESS FOR THE MANUFACTURE OF FONDAPARINUX SODIUM | RELIABLE BIOPHARMACEUTICAL CORPORATION (US) | 2012-05-10 | — | — | US | disclosed |